ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,180.81
-0.13%
US Tech 100
17,584.80
-0.16%
다우존스 지수
38,961.53
0.20%
Bitcoin
62,553.07
0.35%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. CytoSorbents Corporation (CTSO)

  7. CytoSorbents Corporation (CTSO) 뉴스

CTSO CytoSorbents Corporation

0.9066
-0.0256 (-2.75%)
최종 업데이트: 01:57:00
15분 지연
기업명 주식 심볼 시장 주식 타입
CytoSorbents Corporation CTSO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0256 -2.75% 0.9066 01:57:00
개장가 저가 고가 종가 전일 종가
0.9681 0.9044 0.9681 0.9322
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202406:00EDGAR2Form 8-K - Current report
02/05/202420:00GLOBECytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor..
26/04/202420:00GLOBECytoSorbents to Report First Quarter 2024 Operating and..
17/04/202420:00GLOBESTAR-T Pivotal Trial Results to Be Featured as a..
06/03/202421:00GLOBECytoSorbents to Report Fiscal 2023 Operating and Financial..
08/02/202421:00GLOBECytoSorbents to Present at the TD Cowen 44th Annual Health..
18/01/202407:20EDGAR2Form 8-K - Current report
17/01/202421:15GLOBEGroundbreaking Randomized Controlled Trial Reports Excellent..
09/01/202405:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/12/202306:49EDGAR2Form 8-K - Current report
28/12/202321:00GLOBECytoSorbents Provides Update on the STAR-T Trial and Reports..
16/12/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:15EDGAR2Form 8-K - Current report
13/12/202323:15GLOBECytoSorbents Announces Closing of $10.3 Million Registered..
12/12/202306:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/12/202306:10EDGAR2Form 8-K - Current report
10/11/202306:20EDGAR2Form 8-K - Current report
10/11/202306:15GLOBECytoSorbents Reports Third Quarter 2023 Financial and..
10/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/202320:00GLOBECytoSorbents to Report Third Quarter 2023 Operating and..
05/10/202320:00GLOBECytoSorbents to Present at the 8th Annual Dawson James..
27/09/202321:15EDGAR2Form 8-K - Current report
27/09/202320:00GLOBECytoSorbents Highlights Upcoming Presentations at EACTS..
21/09/202322:35GLOBEDawson James Securities Announces October Date for 8th..
21/09/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202305:30EDGAR2Form 8-K - Current report
19/09/202320:00GLOBECytoSorbents Announces Kathleen P. Bloch To Resume as..
13/09/202305:31EDGAR2Form 8-K - Current report
12/09/202300:32GLOBECytoSorb with Ex Vivo Organ Perfusion: Transforming the..
02/09/202305:43GLOBECytoSorbents Announces Resignation of Chief Financial..
02/09/202305:30EDGAR2Form 8-K - Current report
31/08/202320:00GLOBECytoSorbents Granted Expanded ANVISA Registration to Treat..
16/08/202306:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/08/202320:00PRNUSCytoSorbents Completes U.S. and Canadian STAR-T Pivotal..
12/08/202306:30EDGAR2Form 8-K - Current report
09/08/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/08/202305:15GLOBECytoSorbents Reports Second Quarter 2023 Financial and..
02/08/202305:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/07/202320:00GLOBECytoSorbents to Report Second Quarter 2023 Operating and..
20/07/202306:19EDGAR2Form 8-K - Current report
12/07/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
CTSO
CytoSorbents
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유